Loading...

Ultra-Large Volume Wearable Injectors Market by Product Type (Electromechanical Wearable Injector, and Others) and Application (Diabetes, Cancer, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

A03290
Pages: 197
Feb 2020 | 3111 Views
 
Author(s) : Sayali Shinde, Sanjivan Gill , Onkar Sumant
Tables: 82
Charts: 51
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ultra-large Volume Wearable Injectors Market

Request Now !

Ultra-Large Volume Wearable Injectors Market Overview:

The ultra large volume wearable injectors market accounted for $1,408 million in 2018, and is expected to reach $4,066 million by 2026, registering a CAGR of 14.2% from 2019 to 2026. 

Ultra-large volume wearable injectors are defined as the devices, which have the capacity to store large volume of drugs. Furthermore, these devices are designed to stick to the body of the patient and deliver the drug subcutaneously over an extended period of time. The different mechanisms on which these devices work include electromechanical mechanism, mechanical mechanism, and others. For instance, the electromechanical devices deliver drug with the help of an electrical motor, which builds pressure to achieve delivery of the drug. However, some ultra-large volume wearable injectors also work on osmosis mechanism, which involves two chambers of liquid separated by a semipermeable membrane. Thus, the liquid from one chamber is drawn to another chamber upon addition of salt which leads to the generation of mechanical pressure responsible for drug delivery. In addition, there are various benefits associated with the use of these devices such as better patient compliance, easy ambulation, self-administration which lowers the frequency of healthcare professional visits, and others. In addition, these devices are used for the treatment of various chronic conditions such as cancer, diabetes, Parkinson’s diseases, and others.

Ultra-Large Volume Wearable Injectors Market

Get more information on this report : Request Sample Pages

 

The major factor that contributes toward the growth of the ultra large volume wearable injectors market include surge in prevalence of chronic disorders such as diabetes, cancer, and others. Furthermore, other factors such as benefits associated with the use of ultra large volume wearable injectors and rise in adoption of these devices across the globe fuel the growth of the market. 

Moreover, surge in the demand for more advanced treatment options for chronic diseases such as diabetes contributes toward the growth of the ultra-large volume wearable injectors market. In addition, increase in focus by key players toward launch of new products in the market has led to rise in collaborations within the market, which fuels the growth of the market. However, high price of ultra large volume wearable devices restrict the global ultra large volume wearable injectors market growth. In contradiction, presence of ultra large volume wearable devices in development phase, which are expected to be introduced during the forecast period is expected to provide lucrative opportunities for the players in the market

Global Ultra-large Volume Wearable Injectors Market Segmentation  

The ultra large volume wearable injectors market size is studied on the basis of segments product type, application, and region to provide a detailed assessment of the market. By product type, the market is divided into electromechanical wearable injectors and others. By application, it is classified into diabetes, cancer and others. By region, the ultra large volume wearable injector market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment Review

On the basis of product type, the market is divided into electromechanical wearable injector, and others. Electromechanical wearable injector acquired the largest ultra large volume wearable injectors market share in 2018 and is expected to exhibit the fastest growth rate during the forecast period. The growth of this segment is attributable to surge in prevalence cancer and diabetes worldwide. Moreover, rise in awareness related to use of ultra large volume wearable injectors and surge in demand for advanced treatment options for chronic diseases such as diabetes fuel the growth of the market. Furthermore, presence of large number of electromechanical wearable injectors is another major factor that contributes to the ultra-large volume wearable injector market growth.  

Ultra-Large Volume Wearable Injectors Market
By Product Type

Your browser does not support the canvas element.

Electromechanical Wearable Injector segment holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By application, the market is segmented into diabetes, cancer and others, research laboratories, and others. The diabetes segment occupied the largest ultra large volume wearable injectors market share in 2018 and is expected to maintain the lead during the forecast period.

Ultra-Large Volume Wearable Injectors Market
By Application

Your browser does not support the canvas element.

Cancer segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region wise, North America garnered the major share of the ultra-large volume wearable injectors market in 2018, and is expected to continue this trend in the near future, attributable to easy availability of ultra-large volume wearable injectors. Moreover, surge in incidence of chronic disorders such as diabetes and cancer contribute toward the growth of the market in this region. However, Asia-Pacific is projected to register the highest growth during the forecast period, owing to surge in awareness related to the use of ultra-large volume wearable injectors. Furthermore, the constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, and Malaysia.

Ultra-Large Volume Wearable Injectors Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 16.1% during 2019-2026.

Get more information on this report : Request Sample Pages

The global ultra-large volume wearable injectors market is highly competitive, and prominent players have adopted various strategies for garnering maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Amgen Inc., Becton, Dickinson And Company, CeQur SA, Enable Injections, Inc., Gerresheimer AG (Sensile Medical AG), Insulet Corporation, Medtronic plc., Tandem Diabetes Care, Inc., West Pharmaceutical Services, Inc., and Ypsomed Holding AG.

Key Benefits for Stakeholders:

  • This report entails a detailed quantitative analysis along with the current global ultra-large volume wearable injectors market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The ultra-large volume wearable injectors market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the ultra-large volume wearable injectors industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments:

By Product Type

  • Electromechanical Wearable Injectors
  • Others

By Application

  • Diabetes
  • Cancer
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France 
    • UK 
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China 
    • India 
    • Australia 
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments

1.2.1. List of key players profiled in the report

1.3. Research methodology

1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Top player positioning

3.2.1. Top investment pockets

3.3. Key forces shaping ultra large volume wearable injectors industry/market
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of chronic disorders which require the use of ultra large volume wearable injectors for treatment
3.4.1.2. Surge in adoption of ultra large volume wearable injectors across the globe
3.4.1.3. Benefits associated with the use of ultra large volume wearable injectors

3.4.2. Restraint

3.4.2.1. High cost of ultra large volume wearable injectors

3.4.3. Opportunity

3.4.3.1. Presence of products in development phase

3.4.4. Impact Analyses

CHAPTER 4: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Electromechanical Wearable Injector

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country

4.3. Others

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country

CHAPTER 5: ULTRA LARGE VOLUME WEARABLE INJECTORS, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Diabetes

5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country

5.3. Cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country

5.4. Others

5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country

CHAPTER 6: ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. ultra large volume wearable injectors market, by product type
6.2.2.1.2. U.S. ultra large volume wearable injectors market, by application

6.2.2.2. Canada

6.2.2.2.1. Canada ultra large volume wearable injectors market, by product type
6.2.2.2.2. Canada ultra large volume wearable injectors market, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico ultra large volume wearable injectors market, by product type
6.2.2.3.2. Mexico ultra large volume wearable injectors market, by application

6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany ultra large volume wearable injectors market, by product type
6.3.2.1.2. Germany ultra large volume wearable injectors market, by application

6.3.2.2. France

6.3.2.2.1. France ultra large volume wearable injectors market, by product type
6.3.2.2.2. France ultra large volume wearable injectors market, by application

6.3.2.3. UK

6.3.2.3.1. UK ultra large volume wearable injectors market, by product type
6.3.2.3.2. UK ultra large volume wearable injectors market, by application

6.3.2.4. Italy

6.3.2.4.1. Italy ultra large volume wearable injectors market, by product type
6.3.2.4.2. Italy ultra large volume wearable injectors market, by application

6.3.2.5. Spain

6.3.2.5.1. Spain ultra large volume wearable injectors market, by product type
6.3.2.5.2. Spain ultra large volume wearable injectors market, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe ultra large volume wearable injectors market, by product type
6.3.2.6.2. Rest of Europe ultra large volume wearable injectors market, by application

6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan ultra large volume wearable injectors market, by product type
6.4.2.1.2. Japan ultra large volume wearable injectors market, by application

6.4.2.2. China

6.4.2.2.1. China ultra large volume wearable injectors market, by product type
6.4.2.2.2. China ultra large volume wearable injectors market, by application

6.4.2.3. Australia

6.4.2.3.1. Australia ultra large volume wearable injectors market, by product type
6.4.2.3.2. Australia ultra large volume wearable injectors market, by application

6.4.2.4. India

6.4.2.4.1. India ultra large volume wearable injectors market, by product type
6.4.2.4.2. India ultra large volume wearable injectors market, by application

6.4.2.5. South Korea

6.4.2.5.1. South Korea ultra large volume wearable injectors market, by product type
6.4.2.5.2. South Korea ultra large volume wearable injectors market, by application

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Rest of Asia-Pacific ultra large volume wearable injectors market, by product type
6.4.2.6.2. Rest of Asia-Pacific ultra large volume wearable injectors market, by application

6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil ultra large volume wearable injectors market, by product type
6.5.2.1.2. Brazil ultra large volume wearable injectors market, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia ultra large volume wearable injectors market, by product type
6.5.2.2.2. Saudi Arabia ultra large volume wearable injectors market, by application

6.5.2.3. South Africa

6.5.2.3.1. South Africa ultra large volume wearable injectors market, by product type
6.5.2.3.2. South Africa ultra large volume wearable injectors market, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA ultra large volume wearable injectors market, by product type
6.5.2.4.2. Rest of LAMEA ultra large volume wearable injectors market, by application

6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. BECTON, DICKINSON AND COMPANY

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance

7.2. INSULET CORPORATION

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. TANDEM DIABETES CARE, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. YPSOMED HOLDING AG

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance

7.5. ENABLE INJECTIONS, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.5.4. Key strategic moves and developments

7.6. MEDTRONIC PLC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio

7.6.5. Business performance

7.7. AMGEN INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. GERRESHEIMER AG (SENSILE MEDICAL AG)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.8.6. Key strategic moves and developments

7.9. WEST PHARMACEUTICAL SERVICES, INC.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business Performance

7.10. CEQUR SA

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT, 2019-2026 ($MILLION)
TABLE 02. ELECTROMECHANICAL WEARABLE INJECTOR MARKET, BY REGION 2019–2026 ($MILLION)
TABLE 03. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 05. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY REGION 2018–2026($MILLION)
TABLE 06. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR CANCER, BY REGION 2018–2026 ($MILLION)
TABLE 07. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 08. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 10. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 11. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 12. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 13. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 14. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 15. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 16. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 17. NORTH AMERICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 18. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 19. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 20. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 21. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 22. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 23. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 24. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 25. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 26. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 27. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 28. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 29. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 30. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 31. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 32. EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 33. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 34. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 35. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 36. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 37. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 38. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 39. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 40. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 41. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 42. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 43. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 44. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 45. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 46. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 47. ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 48. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 49. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 50. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 51. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 52. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 53. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 54. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 55. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 56. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 57. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY PRODUCT TYPE, 2018–2026
TABLE 58. LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, BY APPLICATION, 2018–2026
TABLE 59. BD: COMPANY SNAPSHOT
TABLE 60. BD: OPERATING SEGMENTS
TABLE 61. BD: PRODUCT PORTFOLIO
TABLE 62. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 63. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 64. TANDEM DIABETES CARE: COMPANY SNAPSHOT
TABLE 65. TANDEM DIABETES CARE: PRODUCT PORTFOLIO
TABLE 66. YPSOMED HOLDING AG: COMPANY SNAPSHOT
TABLE 67. YPSOMED : PRODUCT PORTFOLIO
TABLE 68. ENABLE INJECTIONS: COMPANY SNAPSHOT
TABLE 69. ENABLE INJECTIONS: PRODUCT PORTFOLIO
TABLE 70. MEDTRONIC: COMPANY SNAPSHOT
TABLE 71. MEDTRONIC: OPERATING SEGMENTS
TABLE 72. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 73. AMGEN: COMPANY SNAPSHOT
TABLE 74. AMGEN: PRODUCT PORTFOLIO
TABLE 75. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 76. GERRESHEIMER: OPERATING SEGMENTS
TABLE 77. GERRESHEIMER: PRODUCT PORTFOLIO
TABLE 78. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 79. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 80. WEST PHARMACEUTICAL SERVICES: PRODUCT PORTFOLIO
TABLE 81. CEQUR : COMPANY SNAPSHOT
TABLE 82. CEQUR : PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIER
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. HIGH THREAT OF SUBSTITUTES
FIGURE 07. MODERATE INTENSITY OF RIVALRY
FIGURE 08. LOW THREAT OF NEW ENTRANT
FIGURE 09. IMPACT ANALYSES, ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR ELECTROMECHANICAL WEARABLE INJECTOR, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKETREVENUE FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET REVENUE FOR DIABETES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR CANCER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. U.S. ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 16. CANADA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 17. MEXICO ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 18. GERMANY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 19. FRANCE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 20. UK ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 21. ITALY ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 22. SPAIN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 23. REST OF EUROPE ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 24. JAPAN ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 25. CHINA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 26. AUSTRALIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 27. INDIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 28. SOUTH KOREA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 30. BRAZIL ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 31. SAUDI ARABIA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 32. SOUTH AFRICA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 33. REST OF LAMEA ULTRA LARGE VOLUME WEARABLE INJECTORS MARKET, 2018–2026 ($MILLION)
FIGURE 34. BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 35. BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36. BD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37. INSULET CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. INSULET CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39. TANDEM DIABETES CARE: NET SALES, 2015–2017 ($MILLION)
FIGURE 40. YPSOMED: NET SALES, 2017–2019 ($MILLION)
FIGURE 41. YPSOMED: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42. MEDTRONIC PLC: NET SALES, 2017–2019 ($MILLION)
FIGURE 43. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44. MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45. AMGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 46. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 47. GERRESHEIMER: NET SALES, 2016–2018 ($MILLION)
FIGURE 48. GERRESHEIMER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 49. WEST PHARMACEUTICAL SERVICES: NET SALES, 2016–2018 ($MILLION)
FIGURE 50. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 51. WEST PHARMACEUTICAL SERVICES: REVENUE SHARE BY REGION, 2018 (%)

 
 

Ultra large volume wearable injectors are used to deliver drugs large volume of drugs such as biologicals. These devices have drug solution reservoir with a capacity of 2ml or more. Furthermore, the device releases drugs over an extended period of time through the subcutaneous route for the treatment of diseases such as diabetes, cancer, and others. Moreover, these devices work on various mechanisms such as electromechanical, mechanical, and others.

Factors responsible for driving the growth of the ultra large volume wearable injectors market are rise in surge in prevalence of diseases such as cancer and diabetes and increase in the adoption of these devices. In addition, surge in awareness related to the use of ultra large volume wearable injector across the globe is another prime growth factor that fosters the growth of the global ultra large volume wearable injectors market. However, high price of ultra large volume wearable injector restricts the growth of the global ultra large volume wearable injectors market.

North America garnered the largest share of this market due to rise in research activities related to development of advanced treatment options, easy availability of ultra large volume wearable injector, and presence of key players in the region.

 

 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The total market value of ultra-large volume wearable injectors market is $1,408.30 million in 2018.

A. The forcast period for ultra-large volume wearable injectors market is 2019 to 2026

A. The market value of ultra-large volume wearable injectors market in 2019 is $1,609.90 million

A. The base year is 2018 in ultra-large volume wearable injectors market

A. Top companies such as, Insulet Corporation, Amgen Inc., Tandem Diabetes Care, Inc., Medtronic plc., West Pharmaceutical Services, Inc. held a high market position in 2018.

A. Electromechanical wearable injectors segment is the most influencing segment growing in the ultra-large volume wearable injectors market.

A. The key trend in the ultra-large volume wearable injectors market is the rise in prevalence of chronic disorders which require the use of ultra-large volume wearable injectors for treatment.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 16.1%. The factors which contribute to the growth of market in the region include surge in healthcare expenditure and rise in prevelance of chronic disorders such as diabetes.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Ultra-Large Volume Wearable Injectors Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts